Literature DB >> 20640975

Interpretation of 2002 Centers for Disease Control guidelines for group B streptococcus and evolving provider practice patterns.

Emma L Barber1, Edmund F Funai, Michael B Bracken, Jessica L Illuzzi.   

Abstract

We investigated if clinicians were altering their care of group B streptococcus (GBS)-positive women in labor to achieve 4 hours of intrapartum antibiotic prophylaxis based on their interpretation of the 2002 Centers for Disease Control (CDC) guidelines on prevention of perinatal GBS disease. We surveyed all clinicians with privileges on the labor floor at our institution about their interpretation and clinical application of the 2002 CDC guidelines. Seventy of 96 eligible clinicians (72.9%) completed our survey. In our survey, only 22.9% of clinicians reported not altering their management of labor in GBS-positive pregnancies that achieved less than 4 hours of prophylaxis. These alterations included "laboring down" or delaying pushing; turning off or decrease an oxytocin infusion; or delaying or avoiding artificial rupture of membranes. Clinicians are altering their management of labor to attempt to achieve 4 hours of intrapartum prophylaxis. The 2002 CDC guidelines do not specifically recommend prolonging labor and are being interpreted differently in the clinical setting than the authors may have intended. The effects and consequences of this interpretation are unknown. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20640975      PMCID: PMC3224803          DOI: 10.1055/s-0030-1262907

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  13 in total

1.  Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus.

Authors:  M de Cueto; M J Sanchez; A Sampedro; J A Miranda; A J Herruzo; M Rosa-Fraile
Journal:  Obstet Gynecol       Date:  1998-01       Impact factor: 7.661

2.  Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization.

Authors:  R L Davis; M B Hasselquist; V Cardenas; D M Zerr; J Kramer; A Zavitkovsky; A Schuchat
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

3.  Early-onset and late-onset neonatal group B streptococcal disease--United States, 1996-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-12-02       Impact factor: 17.586

4.  The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.

Authors:  F Y Lin; R A Brenner; Y R Johnson; P H Azimi; J B Philips; J A Regan; P Clark; L E Weisman; G G Rhoads; F Kong; J D Clemens
Journal:  Am J Obstet Gynecol       Date:  2001-05       Impact factor: 8.661

5.  Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery.

Authors:  Emma L Barber; Guomao Zhao; Irina A Buhimschi; Jessica L Illuzzi
Journal:  Obstet Gynecol       Date:  2008-08       Impact factor: 7.661

6.  A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.

Authors:  Stephanie J Schrag; Elizabeth R Zell; Ruth Lynfield; Aaron Roome; Kathryn E Arnold; Allen S Craig; Lee H Harrison; Arthur Reingold; Karen Stefonek; Glenda Smith; Melanie Gamble; Anne Schuchat
Journal:  N Engl J Med       Date:  2002-07-25       Impact factor: 91.245

7.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Authors:  Stephanie Schrag; Rachel Gorwitz; Kristi Fultz-Butts; Anne Schuchat
Journal:  MMWR Recomm Rep       Date:  2002-08-16

8.  Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns.

Authors:  M Pylipow; M Gaddis; J S Kinney
Journal:  Pediatrics       Date:  1994-04       Impact factor: 7.124

9.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission.

Authors:  K M Boyer; C A Gadzala; P D Kelly; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

Review 10.  Epidemiology of group B streptococcal disease in the United States: shifting paradigms.

Authors:  A Schuchat
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  2 in total

1.  Universal versus Risk-Based Management of Unknown Group B Streptococcus Status at Term.

Authors:  Danielle M Jones; Samantha O Haikal; Megan D Whitham; David L Howard
Journal:  AJP Rep       Date:  2019-09-30

2.  Management of group b streptococcus-positive pregnant women at maternity homes in JAPAN: a questionnaire survey of compliance among midwives.

Authors:  Kotomi Yamaguchi; Kazutomo Ohashi
Journal:  Matern Health Neonatol Perinatol       Date:  2018-02-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.